Zobrazeno 1 - 10
of 657
pro vyhledávání: '"Lewcock, JW"'
Autor:
Guo JL; Denali Therapeutics Inc., South San Francisco, CA, USA. Electronic address: guojing84@hotmail.com., Braun D; Denali Therapeutics Inc., South San Francisco, CA, USA., Fitzgerald GA; Denali Therapeutics Inc., South San Francisco, CA, USA., Hsieh YT; Denali Therapeutics Inc., South San Francisco, CA, USA., Rougé L; Denali Therapeutics Inc., South San Francisco, CA, USA., Litvinchuk A; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Steffek M; Denali Therapeutics Inc., South San Francisco, CA, USA., Propson NE; Denali Therapeutics Inc., South San Francisco, CA, USA., Heffner CM; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza C; Denali Therapeutics Inc., South San Francisco, CA, USA., Han SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Rana A; Denali Therapeutics Inc., South San Francisco, CA, USA., Skuja LL; Denali Therapeutics Inc., South San Francisco, CA, USA., Lin BQ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sun EW; Denali Therapeutics Inc., South San Francisco, CA, USA., Davis SS; Denali Therapeutics Inc., South San Francisco, CA, USA., Balasundar S; Denali Therapeutics Inc., South San Francisco, CA, USA., Becerra I; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, CA, USA., Huang F; Denali Therapeutics Inc., South San Francisco, CA, USA., Jain S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kung JE; Denali Therapeutics Inc., South San Francisco, CA, USA., Liau NPD; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon CS; Denali Therapeutics Inc., South San Francisco, CA, USA., Nguyen HN; Denali Therapeutics Inc., South San Francisco, CA, USA., Nguyen N; Denali Therapeutics Inc., South San Francisco, CA, USA., Samaddar M; Denali Therapeutics Inc., South San Francisco, CA, USA., Shi Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Tian Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Suh JH; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Calvert MEK; Denali Therapeutics Inc., South San Francisco, CA, USA., Arguello A; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., Holtzman DM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Koth CM; Denali Therapeutics Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA, USA. Electronic address: dipaolo@dnli.com.
Publikováno v:
Cell [Cell] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.
Autor:
Yulyaningsih E; Denali Therapeutics, South San Francisco, United States., Suh JH; Denali Therapeutics, South San Francisco, United States., Fanok M; Denali Therapeutics, South San Francisco, United States., Chau R; Denali Therapeutics, South San Francisco, United States., Solanoy H; Denali Therapeutics, South San Francisco, United States., Takahashi R; Denali Therapeutics, South San Francisco, United States., Bakardjiev AI; Denali Therapeutics, South San Francisco, United States., Becerra I; Denali Therapeutics, South San Francisco, United States., Benitez NB; Denali Therapeutics, South San Francisco, United States., Chiu CL; Denali Therapeutics, South San Francisco, United States., Davis SS; Denali Therapeutics, South San Francisco, United States., Dowdle WE; Denali Therapeutics, South San Francisco, United States., Earr T; Denali Therapeutics, South San Francisco, United States., Estrada AA; Denali Therapeutics, South San Francisco, United States., Gill A; Denali Therapeutics, South San Francisco, United States., Ha C; Denali Therapeutics, South San Francisco, United States., Haddick PCG; Denali Therapeutics, South San Francisco, United States., Henne KR; Denali Therapeutics, South San Francisco, United States., Larhammar M; Denali Therapeutics, South San Francisco, United States., Leung AW; Denali Therapeutics, South San Francisco, United States., Maciuca R; Denali Therapeutics, South San Francisco, United States., Memarzadeh B; Denali Therapeutics, South San Francisco, United States., Nguyen HN; Denali Therapeutics, South San Francisco, United States., Nugent AA; Denali Therapeutics, South San Francisco, United States., Osipov M; Denali Therapeutics, South San Francisco, United States., Ran Y; Denali Therapeutics, South San Francisco, United States., Rebadulla K; Denali Therapeutics, South San Francisco, United States., Roche E; Denali Therapeutics, South San Francisco, United States., Sandmann T; Denali Therapeutics, South San Francisco, United States., Wang J; Denali Therapeutics, South San Francisco, United States., Lewcock JW; Denali Therapeutics, South San Francisco, United States., Scearce-Levie K; Denali Therapeutics, South San Francisco, United States., Kane LA; Denali Therapeutics, South San Francisco, United States., Sanchez PE; Denali Therapeutics, South San Francisco, United States.
Publikováno v:
ELife [Elife] 2024 Sep 17; Vol. 12. Date of Electronic Publication: 2024 Sep 17.
Autor:
Barker SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Thayer MB; Denali Therapeutics Inc., South San Francisco, CA, USA., Kim C; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Dial R; Denali Therapeutics Inc., South San Francisco, CA, USA., Nilewski L; Denali Therapeutics Inc., South San Francisco, CA, USA., Wells RC; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhou Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Afetian M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Akkapeddi P; Denali Therapeutics Inc., South San Francisco, CA, USA., Chappell A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Chew KS; Denali Therapeutics Inc., South San Francisco, CA, USA., Chow J; Denali Therapeutics Inc., South San Francisco, CA, USA., Clemens A; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza CB; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Dwyer C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Earr T; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Ho YS; Denali Therapeutics Inc., South San Francisco, CA, USA., Huynh D; Denali Therapeutics Inc., South San Francisco, CA, USA., Lozano EI; Denali Therapeutics Inc., South San Francisco, CA, USA., Jayaraman S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kwan W; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon C; Denali Therapeutics Inc., South San Francisco, CA, USA., Pizzo M; Denali Therapeutics Inc., South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Roche E; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanders L; Denali Therapeutics Inc., South San Francisco, CA, USA., Stergioulis A; Denali Therapeutics Inc., South San Francisco, CA, USA., Tong R; Denali Therapeutics Inc., South San Francisco, CA, USA., Tran H; Denali Therapeutics Inc., South San Francisco, CA, USA., Zuchero Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics Inc., South San Francisco, CA, USA., Koth CMM; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Rigo F; Ionis Pharmaceuticals, Carlsbad, CA, USA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Aug 14; Vol. 16 (760), pp. eadi2245. Date of Electronic Publication: 2024 Aug 14.
Autor:
Reich M; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Polke B; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Paris I; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Werner G; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Schrader C; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Spieth L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Max Planck Institute for Multidisciplinary Sciences, 37077 Göttingen, Germany., Davis SS; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Robinson S; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., de Melo GL; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Schlaphoff L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany., Buschmann K; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Berghoff S; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Max Planck Institute for Multidisciplinary Sciences, 37077 Göttingen, Germany., Logan T; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Nuscher B; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., de Weerd L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany., Edbauer D; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Simons M; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Suh JH; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Kariolis MS; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Paquet D; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Capell A; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Jun 05; Vol. 16 (750), pp. eadj7308. Date of Electronic Publication: 2024 Jun 05.
Autor:
Craig RA 2nd; Denali Therapeutics Inc., South San Francisco, California 94080, United States., De Vicente J; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Estrada AA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Feng JA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Lexa KW; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Canet MJ; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Dowdle WE; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Erickson RI; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Flores BN; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Haddick PCG; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Kane LA; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Lewcock JW; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Moerke NJ; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Poda SB; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Sweeney Z; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Takahashi RH; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Tong V; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Wang J; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Yulyaningsih E; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Solanoy H; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Sanchez PE; Denali Therapeutics Inc., South San Francisco, California 94080, United States., Tang L; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Xu M; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Zhang R; Department of Chemistry, WuXi AppTec Co., Ltd., Tianjin 300457, China., Osipov M; Denali Therapeutics Inc., South San Francisco, California 94080, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Apr 11; Vol. 67 (7), pp. 5758-5782. Date of Electronic Publication: 2024 Mar 21.
Autor:
Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Yoon Low RL, Chiu CL, Fang M, Huang F, Bhalla A, Llapashtica C, Prorok R, Pizzo ME, Calvert MEK, Sun EW, Hsiao-Nakamoto J, Rajendra Y, Lexa KW, Srivastava DB, van Lengerich B, Wang J, Robles-Colmenares Y, Kim DJ, Duque J, Lenser M, Earr TK, Nguyen H, Chau R, Tsogtbaatar B, Ravi R, Skuja LL, Solanoy H, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Dennis MS, Kariolis MS, Monroe KM, Przybyla L, Sanchez PE, Meisner R, Diaz D, Henne KR, Watts RJ, Henry AG, Gunasekaran K, Astarita G, Suh JH, Lewcock JW, DeVos SL, Di Paolo G
Publikováno v:
Cell [Cell] 2024 Mar 14; Vol. 187 (6), pp. 1565-1566.
Autor:
Miyamoto T; Denali Therapeutics Inc, South San Francisco, California, USA., Kim C; Denali Therapeutics Inc, South San Francisco, California, USA., Chow J; Denali Therapeutics Inc, South San Francisco, California, USA., Dugas JC; Denali Therapeutics Inc, South San Francisco, California, USA., DeGroot J; Denali Therapeutics Inc, South San Francisco, California, USA., Bagdasarian AL; Denali Therapeutics Inc, South San Francisco, California, USA., Thottumkara AP; Denali Therapeutics Inc, South San Francisco, California, USA., Larhammar M; Denali Therapeutics Inc, South San Francisco, California, USA., Calvert ME; Denali Therapeutics Inc, South San Francisco, California, USA., Fox BM; Denali Therapeutics Inc, South San Francisco, California, USA., Lewcock JW; Denali Therapeutics Inc, South San Francisco, California, USA. Electronic address: lewcock@dnli.com., Kane LA; Denali Therapeutics Inc, South San Francisco, California, USA. Electronic address: kane@dnli.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Feb; Vol. 300 (2), pp. 105630. Date of Electronic Publication: 2024 Jan 08.
Autor:
Benatar M; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA., Ostrow LW; Department of Neurology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.; CReATe Biomarkers External Advisory Committee., Lewcock JW; CReATe Biomarkers External Advisory Committee.; Denali Therapeutics, South San Francisco, CA, USA., Bennett F; CReATe Biomarkers External Advisory Committee.; Ionis Pharmaceuticals, Carlsbad, CA, USA., Shefner J; CReATe Biomarkers External Advisory Committee.; Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA., Bowser R; CReATe Biomarkers External Advisory Committee.; Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA., Larkin P; The ALS Association, Arlington, VA, USA., Bruijn L; CReATe Biomarkers External Advisory Committee.; Novartis Pharmaceuticals UK, London, UK., Wuu J; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
Publikováno v:
Annals of neurology [Ann Neurol] 2024 Feb; Vol. 95 (2), pp. 211-216. Date of Electronic Publication: 2023 Dec 28.
Autor:
Iwatsubo T; The University of Tokyo, Tokyo 113-0033, Japan iwatsubo@m.u-tokyo.ac.jp.; National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan., Irizarry MC; Eisai Inc., Nutley, New Jersey 07110., Lewcock JW; Denali Therapeutics, South San Francisco, California 94080., Carrillo MC; Alzheimer's Association, Chicago, Illinois 60601.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2023 Nov 22; Vol. 43 (47), pp. 7894-7898. Date of Electronic Publication: 2023 Nov 22.
Autor:
Wang X; Denali Therapeutics, South San Francisco, United States., Bondar VV; Denali Therapeutics, South San Francisco, United States., Davis OB; Denali Therapeutics, South San Francisco, United States., Maloney MT; Denali Therapeutics, South San Francisco, United States., Agam M; Denali Therapeutics, South San Francisco, United States., Chin MY; Denali Therapeutics, South San Francisco, United States., Cheuk-Nga Ho A; Denali Therapeutics, South San Francisco, United States., Ghosh R; Denali Therapeutics, South San Francisco, United States., Leto DE; Denali Therapeutics, South San Francisco, United States., Joy D; Denali Therapeutics, South San Francisco, United States., Calvert MEK; Denali Therapeutics, South San Francisco, United States., Lewcock JW; Denali Therapeutics, South San Francisco, United States., Di Paolo G; Denali Therapeutics, South San Francisco, United States., Thorne RG; Denali Therapeutics, South San Francisco, United States.; Department of Pharmaceutics, University of Minnesota, Minneapolis, United States., Sweeney ZK; Denali Therapeutics, South San Francisco, United States., Henry AG; Denali Therapeutics, South San Francisco, United States.
Publikováno v:
ELife [Elife] 2023 Oct 24; Vol. 12. Date of Electronic Publication: 2023 Oct 24.